Early Readmissions More Preventable Than Later Ones

Share this content:
Early Readmissions More Preventable Than Later Ones
Early Readmissions More Preventable Than Later Ones

TUESDAY, May 1, 2018 (HealthDay News) -- Early general medicine readmissions are more likely than late readmissions to be preventable with hospital-based interventions, according to a study published online May 1 in the Annals of Internal of Medicine.

Kelly L. Graham, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues examined data from 822 adults readmitted to a general medicine service at 10 academic medical centers in the United States. A structured survey instrument was used to determine whether readmissions within seven days of discharge differed from those between eight and 30 days after discharge regarding preventability.

The researchers found that 36.2 percent of early readmissions were preventable versus 23 percent of late readmissions. For preventing early readmissions, hospitals were better locations (median risk difference, 22.8 percentage points). In contrast, for preventing late readmissions, outpatient clinics (median risk difference, 10 percentage points) and home (median risk difference, 5.6 percentage points) were better locations.

"We believe it is time to change the model for patient outcomes after hospital discharge to one that recognizes shared accountability for readmissions along the entire spectrum of care," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »